Teladoc Health, INC 8-K filings

Teladoc Health announced the appointment of Mark V. Anquillare, former COO of Verisk Analytics, to its board of directors, enhancing its financial and strategic oversight.

Teladoc Health, Inc. announced the results of its 2026 Annual Meeting of Stockholders, with all director nominees elected and executive compensation approved.

Teladoc Health reported a 2% year-over-year revenue decrease to $613.8 million for Q1 2026, with a net loss of $63.8 million, though the net loss per share improved significantly.

Teladoc Health announced the appointment of Susan R. Salka, former AMN Healthcare CEO, to its Board of Directors and key committees.

Teladoc Health reported a significantly reduced full-year net loss and flat fourth-quarter revenue, with mixed segment performance.

Teladoc Health, Inc. announced that director Thomas G. McKinley will retire from its Board effective February 20, 2026, citing personal reasons.

Teladoc Health, Inc. announced that director J. Eric Evans will not seek reelection and plans to retire from the Board after the 2026 Annual Meeting for personal reasons.

Teladoc Health, Inc. increased the number of shares reserved under its 2023 Employment Inducement Incentive Award Plan by 1.78 million to a total of 7.28 million shares.

Teladoc Health reported a 2% year-over-year revenue decrease and a widened net loss of $49.5 million for Q3 2025, though results were in the upper half of guidance.

Teladoc Health announced its CFO, Mala Murthy, will resign effective November 21, 2025, while reaffirming its full-year 2025 consolidated financial outlook and providing preliminary third-quarter results.

Teladoc Health reported a 2% year-over-year revenue decrease to $631.9 million in Q2 2025, driven by a 9% decline in its BetterHelp segment, while significantly reducing net loss and maintaining positive free cash flow.

Teladoc Health, Inc. has entered into a new five-year, $300 million senior secured revolving credit facility to enhance its financial and operational flexibility, with no immediate plans for borrowing.

Teladoc Health, Inc. announced that its stockholders approved all proposals at the 2025 Annual Meeting, including the election of directors, executive compensation, and a significant increase in shares available for its 2023 Incentive Award Plan.

Teladoc Health's first quarter 2025 results show a slight revenue decrease but include the acquisition of UpLift Health Technologies to bolster its mental health services.

Teladoc Health's full year 2024 revenue declined slightly, with a significant increase in net loss, while the company initiates 2025 guidance including the anticipated contribution from the acquisition of Catapult Health.

Teladoc Health's third quarter 2024 results show a 3% year-over-year revenue decrease, with growth in Integrated Care partially offsetting a decline in BetterHelp revenue.

Teladoc Health's Chief Operating Officer, Michael Waters, has resigned effective December 31, 2024, due to a change in the company's executive reporting structure.

Teladoc Health has appointed Joseph Catapano as its new Senior Vice President and Chief Accounting Officer, effective September 9, 2024.

Teladoc Health's second quarter results show a revenue decrease of 2% year-over-year and a substantial net loss due to a goodwill impairment charge, despite growth in the Integrated Care segment and adjusted EBITDA.

Teladoc Health has terminated the employment of its President of Enterprise Growth and Global Markets, Laizer Kornwasser, as part of an executive restructuring.

Teladoc Health has appointed Charles Divita III as its new Chief Executive Officer, effective June 10, 2024, marking a significant leadership change for the virtual care company.

Teladoc Health's 2024 Annual Meeting saw the election of directors, approval of executive compensation, and ratification of the company's accounting firm.

Teladoc Health's first quarter 2024 results show a 3% revenue increase year-over-year, but a widening net loss despite a 20% jump in adjusted EBITDA.

Teladoc Health's Chief Accounting Officer, Richard J. Napolitano, has resigned effective May 3, 2024, and will be temporarily replaced by James L. Cave.

Teladoc Health's CEO Jason Gorevic is departing, with CFO Mala Murthy appointed as acting CEO, while the company reaffirms its financial guidance for 2024.

Teladoc Health's full year 2023 results show revenue growth of 8% and a significant increase in adjusted EBITDA of 33%, marking the company's most profitable year to date.